Recent clinical studies suggest that BRCA1+TP53+ TNBC cases had better OS chances than BRCA1−TP53− cases and, in fact, the survival ability of breast cancer patients goes down when both BRCA1 and TP53 are affected (Kim et al., 2016). Here, BRCA1 is linked to breast carcinoma.